AZ-Oxford vaccine safe & efficacious: Interim analysis

“ChAdOx1 nCoV-19 has an acceptable safety profile and has been found to be efficacious against symptomatic Covid-19 in this interim analysis of ongoing clinical trials,” the Lancet said.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news